Cramer highlights 3 stocks to watch in a deeply oversold market that's bouncing Friday

• Here are the 3 things behind the Friday stock market rally that almost wasn't

  Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
  
  CNBC - 2h

• Jim Cramer's top 10 things to watch in the stock market Friday

  Wall Street was back in the soup Friday morning but trimming some losses on a cooler inflation reading.
  
  CNBC - 7h

• Jim Cramer's top 10 things to watch in the stock market Thursday

  Wall Street looked to rebound from Wednesday's 1,100 point Dow drop following the Fed's revised rate outlook.
  
  CNBC - 1d

• Jim Cramer's top 10 things to watch in the stock market Wednesday

  Wall Street was looking at a higher open after the Dow closed lower for the ninth straight session for the first time since 1978.
  
  CNBC - 2d

• After taking morning profits, we're afternoon buyers of 2 stocks in an oversold market

  This is our second trade alert of the day.
  
  CNBC - 3d

• Jim Cramer's top 10 things to watch in the stock market Friday

  The takeaway from Broadcom's earnings: There's insatiable demand for AI chips from the tech titans.
  
  CNBC - Dec. 13

• Jim Cramer's top 10 things to watch in the stock market Wednesday

  Inflation for November came in as expected. Plus, General Motors called it quits on Cruise.
  
  CNBC - Dec. 11

• Jim Cramer's top 10 things to watch in the stock market Thursday

  Shares of companies holding cryptocurrency and enabling trading surged as bitcoin topped $100,000 for the first time ever.
  
  CNBC - Dec. 5

• Jim Cramer's top 10 things to watch in the stock market Wednesday

  Eli Lilly crushed Novo Nordisk's in a head-to-head obesity drug trial. Salesforce and Marvell shares surged on earnings.
  
  CNBC - Dec. 4

More from CNBC

• CFPB sues JPMorgan Chase, Bank of America and Wells Fargo over Zelle payment fraud

  CNBC - 2h

• Key Fed inflation measure shows 2.4% rate in November, lower than expected

  CNBC - 7h

• OpenAI is done with Shipmas and staring down daunting challenges for 2025

  CNBC - 3h

• FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

  CNBC - 9m

• Warren Buffett's Berkshire Hathaway scoops up Occidental and other stocks during sell-off

  CNBC - 5h